Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 8;4(14):293-297.
doi: 10.46234/ccdcw2022.074.

Association of COVID-19 Vaccination and Clinical Severity of Patients Infected with Delta or Omicron Variants - China, May 21, 2021-February 28, 2022

Affiliations

Association of COVID-19 Vaccination and Clinical Severity of Patients Infected with Delta or Omicron Variants - China, May 21, 2021-February 28, 2022

Mingshuang Li et al. China CDC Wkly. .

Abstract

What is already known about this topic?: Compared with the international mRNA and adenovirus-vectored coronavirus disease 2019 (COVID-19) vaccines, there is less real-world research data about breakthrough cases in people vaccinated with China-made COVID-19 vaccines. Analyses of clinical outcomes of breakthrough cases will be an important supplement to the clinical trial efficacy and observational effectiveness data of China-made COVID-19 vaccines.

What is added by this report?: COVID-19 vaccine age-eligible individuals (≥3 years old) who received full primary series and a booster dose of China-made COVID-19 vaccines had good protection from pneumonia caused by Delta variant infection. There was only one serious Delta case in children (unvaccinated), but among adults 18 years and older, there was good protection from serious illness with primary vaccination and booster vaccination. Among people ≥60 years, full vaccination and booster vaccination were associated with protection from pneumonia and risk of serious COVID-19 caused by Omicron variant infection. There were few serious Omicron cases.

What are the implications for public health practice?: Everyone 3 years and older without contraindications should be fully vaccinated against COVID-19; schedule-eligible adults should receive booster doses. The pace of booster dose administration, especially among the elderly, should be accelerated.

Keywords: COVID-19; clinical severity.; vaccinations.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Age-specific COVID-19 vaccination status among Delta- and Omicron-infected cases, China, May 21, 2021–February 28, 2022.

References

    1. Our World in Data. Coronavirus (COVID-19) Vaccinations. https://ourworldindata.org/covid-vaccinations. [2022-3-26].

    1. National Health Commission of China. Protocol for prevention and control of COVID-19 in China (Edition8). http://www.nhc.gov.cn/xcs/zhengcwj/202105/6f1e8ec6c4a540d99fafef52fc86d0f8.shtml. [2022-3-26]. (In Chinese).

    1. Tenforde MW, Self WH, Adams K, Gaglani M, Ginde AA, McNeal T, et al Association between mRNA vaccination and COVID-19 hospitalization and disease severity. JAMA. 2021;326(20):2043–54. doi: 10.1001/jama.2021.19499. - DOI - PMC - PubMed
    1. Li Ka Shing Faculty of Medicine, The University of Hong Kong. Forward planning after HK’s fifth wave of Omicron BA.2. http://www.med.hku.hk/zh-HK/news/press/20220322-updates-on-modelling-the-omicron-fifth-wave. [2022-3-26].

    1. Nemet I, Kliker L, Lustig Y, Zuckerman N, Erster O, Cohen C, et al Third BNT162b2 vaccination neutralization of SARS-CoV-2 omicron infection. N Engl J Med. 2022;386(5):492–4. doi: 10.1056/NEJMc2119358. - DOI - PMC - PubMed

LinkOut - more resources